socalTECH

MARCH 2, 2010

Thousand Oaks-based Teledyne Technologies announced today that it has acquired a minority interest in Optical Alchemy , a Nashua, New Hampshire-based designer and manufacturer of ultra-light electro optical gimbal systems. Financial terms of the investment were not disclosed. READ MORE>>.

Invest 150

Invest Thousand Oaks Design Capital 150

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners. As part of the funding, F-Prime's Thomas Beck and Ben Auspitz have joined the company's board.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

OCTOBER 17, 2016

Thousand Oaks-based Amgen said late Friday that it has named Ellen J. Kullman to its board of directors, expanding the company's board to a total of 14 directors. Kullman is the former President, Chair, and CEO of E.I. du Pont de Nemours and Company (Dupont). READ MORE>>.

Thousand Oaks 100

Thousand Oaks Invest Technology Company 100

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. USVP has backed such companies as Sun Microsystems, New Focus, Check Point Software Technologies, and hundreds of others. Bowes founded USVP after spending nearly 25 years at investment banking firm Blyth & Co.,

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Teledyne made its initial investment in Ocean Aero in July of 2014.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

APRIL 1, 2011

Thousand Oaks-based Teledyne Technologies said this morning that it has acquired a minority stake in Optech , a developer of three dimensional, lidar-based imaging systems. Teledyne said the investment was made through its subsidiary, Teledyne DALSA. Financial details of the acquisition were not disclosed.

Thousand Oaks 145

Thousand Oaks Acquisition Invest Technology 145